Skip to main content
Navigate Up
Sign In
Children's Hospital Colorado -

Maahs Awarded 5-Year, $2.4 Million Grant For Kidney Research



Kidney disease poses one of the greatest burdens for people living with type 1 diabetes. A study newly awarded by the National Institutes of Health (NIH) will look at whether lowering uric acid levels can prevent people with type 1 diabetes from needing hemodialysis or kidney transplant.

David Maahs, MD, PhD ,associate professor of Pediatrics at the University of Colorado School of Medicine, Barbara Davis Center for Childhood Diabetes has been awarded a 5-year grant for $2.4 million dollars to evaluate the benefit of a drug called allopurinol, an FDA approved drug to lower uric acid. The money is part of a larger $24.3 million grant to the Joslin Diabetes Center.​